EHR

Oracle Recognized as a Leader in Everest Group PEAK Matrix® for Life Sciences Clinical Trial Management System (CTMS) Assessment 2024

Highlights ease of deployment, value, and extensibility of comprehensive Oracle platform ORLANDO, Fla. , Feb. 3, 2025 /PRNewswire/ -- SCOPE 2025 – Oracle…

11 months ago

IgniteData Expands EHR-to-EDC Capabilities with Yunu Integration for Imaging Data in Clinical Trials

WILMINGTON, Del., Feb. 3, 2025 /PRNewswire/ -- IgniteData, a leader in EHR-to-EDC interoperability for clinical trials, has partnered with Yunu…

11 months ago

Embrace the Future of Health IT and the Power of MEDITECH Expanse at HIMSS25

Visit booth #972 to learn why Expanse is the intelligent EHR platform driving care transformationCANTON, Mass.--(BUSINESS WIRE)--Join MEDITECH at HIMSS25,…

11 months ago

Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

EHR solution receives top rankings for ease of navigation, telehealth integration and client experience, amplifying company's commitment to supporting ambulatory…

11 months ago

Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

EHR solution receives top rankings for ease of navigation, telehealth integration and client experience, amplifying company's commitment to supporting ambulatory…

11 months ago

Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

EHR solution receives top rankings for ease of navigation, telehealth integration and client experience, amplifying company's commitment to supporting ambulatory…

11 months ago

Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

EHR solution receives top rankings for ease of navigation, telehealth integration and client experience, amplifying company's commitment to supporting ambulatory…

11 months ago

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

Funding will Support Ongoing RIDGE™-1 Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular…

11 months ago

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

Funding will Support Ongoing RIDGE™-1 Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular…

11 months ago

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

Funding will Support Ongoing RIDGE™-1 Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular…

11 months ago